Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has disclosed Operating Leases for 6 consecutive years, with $2000.0 as the latest value for Q4 2024.

  • Quarterly Operating Leases fell 99.88% to $2000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2024, down 99.88% year-over-year, with the annual reading at $2000.0 for FY2024, 99.88% down from the prior year.
  • Operating Leases for Q4 2024 was $2000.0 at Iradimed, down from $2831.0 in the prior quarter.
  • The five-year high for Operating Leases was $2.7 million in Q1 2020, with the low at $2000.0 in Q4 2024.
  • Average Operating Leases over 5 years is $1.8 million, with a median of $2.0 million recorded in 2022.
  • The sharpest move saw Operating Leases fell 8.44% in 2020, then plummeted 99.88% in 2024.
  • Over 5 years, Operating Leases stood at $2.5 million in 2020, then fell by 10.32% to $2.2 million in 2021, then decreased by 13.32% to $1.9 million in 2022, then decreased by 15.52% to $1.6 million in 2023, then tumbled by 99.88% to $2000.0 in 2024.
  • According to Business Quant data, Operating Leases over the past three periods came in at $2000.0, $2831.0, and $4231.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.